Community-acquired methicillin-resistant Staphylococcus aureus skin infections: Implications for patients and practitioners

American Journal of Clinical Dermatology

Volumn 8, Issue 5, 2007, Pages 259-270

  Cohen, Philip R ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFALEXIN; CEFDINIR; CEFTOBIPROLE; CEPHALOSPORIN; CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DICLOXACILLIN; DOXYCYCLINE; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; ORITAVANCIN; POVIDONE IODINE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFADIAZINE SILVER; TEICOPLANIN; TELAVANCIN; TETRACYCLINE DERIVATIVE; TIGECYCLINE; TRICLOSAN; VANCOMYCIN;

ABSCESS DRAINAGE; ADJUVANT THERAPY; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ATOPIC DERMATITIS; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CELLULITIS; CRITICALLY ILL PATIENT; FOLLICULITIS; HIGH RISK POPULATION; HUMAN; IMPETIGO; INCIDENCE; INSECT BITE; MEDICAL LITERATURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; PARONYCHIA; PATHOGENESIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN ABSCESS; SKIN INCISION; SKIN INFECTION; SKIN MANIFESTATION; SOCIOECONOMICS; SPIDER BITE; STAPHYLOCOCCUS INFECTION; VACCINATION;

EID: 35148813511     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200708050-00001     Document Type: Review

References (65)

1. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention. Int J Dermatol 2007; 46: 1-11
2. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 2005; 80: 1201-8
3. DelGiudice P, Blanc V, Durupt F, et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006; 154: 118-24
4. Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol 2007; 56: 1-16
5. Drews TD, Temte JL, Fox BC. Community-associated methicillin-resistant Staphylococcus aureus: review of an emerging public health concern. Wisconsin Med J 2006; 105 (1): 52-7
6. Grundmann H, Aires-de-Sousa M, Boyce J, et al. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874-85
7. Kaplan SK. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis 2006; 17: 113-9
8. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection: a personal perspective of a world-wide epidemic. Expert Rev Dermatol 2006; 1: 631-7
9. Cohen PR, Kurzrock R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. J Am Acad Dermatol 2004; 50: 277-80
10. Cohen PR, Grossman ME. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 2004; 51: 132-5
11. Nimmo GR, Coombs GW, Pearson JC, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Australia 2006; 184: 384-8
12. Paintsil E. Pediatric community-acquired methicillin-resistant Staphylococcus aureus infection and colonization: trends and management. Curr Opin Pediatr 2007; 19: 75-82
13. Cunha BA. Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. Clin Microbiol Infect 2005; 11 Suppl. 4: 33-42
14. Rybak MJ, LaPlante KL. Community-associated methicillin-resistant Staphylococcus aureus: a review. Pharmacotherapy 2005; 25: 74-85
15. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus. JAMA 2003; 290: 2976-84
16. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005; 41: S269-72
17. Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy 2006; 26: 1758-70
18. Szumowski JD, Cohen DE, Kanaya F, et al. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007; 51: 423-8
19. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007; 87: 3-9
20. Singer J, Dowler M, Bosscher B. Emergency department perspective on methicillin-resistant Staphylococcus aureus. Pediatr Emergency Care 2006; 22: 270-6
21. Frank AL, Marcinak JF, Mangat PD, et al. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis 1999; 18: 993-1000
22. Huijsdens XW, van Santen-Verheuvel MG, Spalburg E, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44: 2994-6
23. Centers for Disease Control and Prevention. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns: Chicago and Los Angeles county, 2004. Morb Mortal Wkly Rep 2006; 55: 329-32
24. Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118: 874-81
25. Gilbert M, MacDonald J, Gregson D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness, or incarceration. Canadian Med Assoc 2006; 175: 149-54
26. Crum-Cianflone N, Hale B, Burgi A, et al. TriService AIDS Clinical Consortium: increasing rates of community-acquired MRSA infections among HIV-infected persons [abstract MOAB0304: oral abstract session 8-14-06, 15: 00-15:15 (SR9)]. XVI International AIDS Conference; 2006 Aug 13-18; Toronto, Canada. Clin Infect Dis 2006; 43 (8): iii
27. Chen KT, Huard RC, Della-Latta P, et al. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol 2006; 108: 482-7
28. Gibbs RS. Emerging infections in obstetric and gynecologic practice. Obstet Gynecol 2006; 108: 480-1
29. Ruhe JJ, Monson T, Bradsher RW, et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005; 40: 1429-34
30. Stemper ME, Brady JM, Qutaishat SS, et al. Shift in Staphylococcus aureus clone linked to an infected tattoo. Emerg Infect Dis 2006; 12: 1444-6
31. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients: Ohio, Kentucky, and Vermont, 2004-2005. Morb Mortal Wkly Rep 2006; 55: 677-9
32. Bratu S, Landman D, Gupta J, et al. A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City. Ann Clin Microbiol Microbials 2006; 5: 29
33. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as an axillary abscess with cellulitis in a college athlete. SKINmed: Dermatology for the Clinician 2005; 4: 115-8
34. Cohen PR. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities. South Med J 2005; 98: 596-602
35. Cohen PR. The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus in athletes. Clin Dermatol. In press
36. Huijsdens XW, van Lier AMC, van Kergten E, et al. Methicillin-resistant Staphylococcus aureus in Dutch soccer team. 2006; 12: 1584-6
37. Cook HA, Furuya EY, Larson E, et al. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007; 44: 410-3
38. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus: an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003; 16: 103-24
39. Suh LM, Honig PJ, Yan AC. Methicillin-resistant Staphylococcus aureus skin abscess in a pediatric patient with atopic dermatitis: a case report. Cutis 2006; 78: 113-6
40. Roesch A, Linde H-J, Landthaler M, et al. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis: critical situations. Arch Dermatol 2005; 141: 1520-2
41. Aly R, Maibach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977; 113: 780-2
42. Arkwright PD, Daniel TO, Sanyal D, et al. Age-related prevalence and antibiotic resistance of pathogenic Staphylococci and Streptococci in children with infected atopic dermatitis at a single-specialty center. Arch Dermatol 2002; 138: 939-41
43. Hon KLE, Lam MCA, Leung TF, et al. Clinical features associated with nasal Staphylococcus aureus colonisation in Chinese children with moderate-to-severe atopic dermatitis. Ann Acad Med Singapore 2005; 34: 602-5
44. Klein PA, Greene WH, Fuhrer J, et al. Prevalence of methicillin-resistant Staphylococcus aureus in outpatients with psoriasis, atopic dermatitis, or HIV infection. Arch Dermatol 1997; 133: 1463-5
45. Nakata K, Inoue Y, Harada J, et al. A high incidence of Staphylococcus aureus colonization in the external eyes of patients with atopic dermatitis. Ophthalmology 2000; 107: 2167-71
46. Oshima Y, Ohji M, Inoue Y, et al. Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis. Ophthalmology. 1999; 106: 142-7
47. Setyadi HG, Cohen PR, Schulze KE, et al. Trigeminal trophic syndrome. South Med J 2007; 100: 43-8
48. Konstantopoulou M, O'Dwyer EM, Steele JC, et al. Pyodermatitis- pyostomatitis vegetans complicated by methicillin-resistant Staphylococcus aureus infection. Clin Exp Dermatol 2005; 30: 666-8
49. Scoffle NN, Cohen PR. Images in clinical medicine: Sarcopetes scabiei infestation. N Engl J Med 2004; 350 (22): e20
50. Cohen PR. What caused this abscess and cellulitis? Diagnosis: community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) skin infection. Skin & Aging 2004; 12 (10): 56-8
51. Cohen PR. Enlarging facial abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus). Cortlandt Forum 2005; 18 (4): 42, 45
52. Cohen PR. Enlarging abscess with cellulitis (community-acquired methicillin-resistant Staphylococcus aureus). Clin Advisor 2005; 8 (9): 60, 63
53. Cohen PR. Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as a periumbilical folliculitis: case reports. Cutis 2006; 77: 229-31
54. Pagac BB, Reiland RW, Bolesh DT, et al. Skin lesions in barracks: consider community-acquired methicillin-resistant Staphylococcus aureus infection instead of spider bites. Mil Med 2006; 171: 830-2
55. Miller LG, Spellberg B. Treatment of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections with drainage but no antibiotic therapy [letter]. Pediatr Infect Dis J 2004; 23: 795
56. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin- resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23: 123-7
57. Rios AM, Lee MC, Hardy RD. Staphylococcal skin infections: reply. Pediatr Infect Dis J 2004; 23: 795-6
58. Barnes 2nd EV, Dooley DP, Hepburn MJ, et al. Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections with antibiotics other than vancomycin. Mil Med 2006; 171: 504-7
59. Cohen PR. Empiric treatment of skin infections: Dr. Cohen responds [letter]. Clin Advisor 2006, 12
60. Cohen PR. Cutaneous MRSA treatment (87-6) [advisor forum]. Clin Advisor 2006; 9 (1): 54
61. Ashourian N, Cohen PR. Systemic drugs for infectious diseases (chapter 4). In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 2nd ed. Philadelphia (PA): Saunders Elsevier, 2007: 39-74
62. Carter MK, Ebers VA, Younes BK, et al. Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections. Ann Pharmacotherapy 2006; 40: 1693-5
63. Drew RH. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy 2007; 27: 227-49
64. John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatr Clin N Am 2006; 53: 699-713
65. Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Natl Acad Sci 2006; 103: 16942-7